Piramal Enterprises Stock Forecast for 2023 - 2025 - 2030
Updated on 03/29/2024
Piramal Enterprises Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for Piramal Enterprises were recently set by four distinguished experts, with an average mark of Rp1000.00. If it reached this goal, it would represent a potential upside of approximately 15.09% from the previous closing price in March, 2024. The high end is Rp1250.00, and the low is Rp775.00. If you are looking to invest in the stock, it's important to research and compare different companies.
15.09% Upside
Piramal Enterprises Fair Value Forecast for 2023 - 2025 - 2030
Piramal Enterprises's Price has grown in the last three years, jumping from Rp1229.61 to Rp1716.48 – an increase of 39.60%. According to the 5 analysts polled, in the next year, Piramal Enterprises's Fair Value will fall by 18.15%, reaching Rp1404.87. For the next seven years, the forecast is for Fair Value to grow by 2.52%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$161.23 | Buy/Sell | $174.55 | 5.44% |
MRK Stock Forecast | Merck | Outperform |
2
|
$122.77 | Buy/Sell | $130.51 | 9.96% |
TMO Stock Forecast | Thermo Fisher Scientific | Outperform |
10
|
$599.43 | Buy/Sell | $591.94 | 0.10% |
ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$120.19 | Buy/Sell | $118.92 | 4.83% |
AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£104.50 | Buy/Sell | £165.99 | 53.79% |
Piramal Enterprises Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Piramal Enterprises has seen a decline in its Revenue, from Rp134.01B to Rp50.96B – a 61.97% decrease. According to the 7 analysts polled, in the next year, Piramal Enterprises's Revenue will fall by 1.63%, reaching Rp50.13B. For the next seven years, the forecast is for Revenue to grow by 25.59%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
NOVN Stock Forecast | Novartis | Outperform |
10
|
CHF88.80 | Buy/Sell | CHF105.00 | 23.95% |
AMGN Stock Forecast | Amgen | Outperform |
4
|
$275.36 | Buy/Sell | $303.65 | 14.40% |
HDFCBANK Stock Forecast | HDFC Bank | Buy |
8
|
Rp1.43k | Buy/Sell | Rp1.93k | 35.73% |
Piramal Enterprises Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Piramal Enterprises's Dividend per Share has increased by 121.43%, going from Rp14.00 to Rp31.00. For the next year, 6 analysts project Piramal Enterprises's Dividend per Share to drop by 41.03%, reaching Rp18.28. By 2030, professionals believe that Piramal Enterprises's Dividend per Share will decrease by 18.58%, reaching Rp25.24 – a concerning trend for the company.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$54.36 | Buy/Sell | $58.15 | 1.18% |
GILD Stock Forecast | Gilead Sciences Inc | Outperform |
11
|
$75.32 | Buy/Sell | $87.82 | 10.20% |
ICICIBANK Stock Forecast | ICICI Bank | Buy |
9
|
Rp1.08k | Buy/Sell | Rp1.19k | 13.79% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
GSK Stock Forecast | GSK | Outperform |
12
|
£16.75 | Buy/Sell | £17.30 | 11.04% |
500696 Stock Forecast | Hindustan Unilever | Outperform |
10
|
Rp2.39k | Buy/Sell | Rp2.75k | 14.76% |
500010 Stock Forecast | Housing Development Finance Co... | - |
9
|
Rp2.73k | Buy/Sell | Rp3.23k | -42.32% |
Piramal Enterprises EBITDA Forecast for 2023 - 2025 - 2030
Piramal Enterprises's EBITDA has decreased In the last two years, from Rp85.51B to Rp70.46B – a 17.60% drop. In the next year, analysts expect EBITDA to reach Rp77.00B – an increase of 9.29%. For the next eight years, the forecast is for EBITDA to grow by 9.72%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
500510 Stock Forecast | Larsen & Toubro | Outperform |
8
|
Rp3.64k | Buy/Sell | Rp3.22k | 12.03% |
BAJFINANCE Stock Forecast | Bajaj Finance | Outperform |
9
|
Rp6.43k | Buy/Sell | Rp8.56k | 36.78% |
SUNPHARMA Stock Forecast | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.59k | Buy/Sell | Rp1.52k | -1.42% |
Piramal Enterprises EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Piramal Enterprises's EBIT has seen a drop from Rp80.80B to Rp64.72B – a 19.90% decrease. According to 5 major analysts, Piramal Enterprises's EBIT will fall by 68.38% in the next year, reaching Rp20.46B. Professionals believe that By 2030, Piramal Enterprises's EBIT will fall to Rp43.62B– a 32.61% decrease from its current value.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
500247 Stock Forecast | Kotak Mahindra Bank | Outperform |
9
|
Rp1.73k | Buy/Sell | Rp2.07k | 21.44% |
532215 Stock Forecast | Axis Bank | Buy |
9
|
Rp1.10k | Buy/Sell | Rp1.17k | 15.22% |
LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF458.20 | Buy/Sell | CHF516.89 | 12.61% |
Piramal Enterprises EPS Price Prediction Forecast for 2023 - 2025 - 2030
Piramal Enterprises's EPS has grown in the last three years, jumping from Rp56.90 to Rp79.43 – an increase of 39.60%. According to the 5 analysts polled, in the next year, Piramal Enterprises's EPS will fall by 18.15%, reaching Rp65.01. For the next seven years, the forecast is for EPS to grow by 2.52%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
DSFIR Stock Forecast | DSM-Firmenich | Outperform |
18
|
104.30€ | Buy/Sell | 114.60€ | 15.05% |
DLF Stock Forecast | DLF | Outperform |
15
|
Rp911.25 | Buy/Sell | Rp601.47 | -9.90% |
SY1 Stock Forecast | Symrise | Outperform |
18
|
107.30€ | Buy/Sell | 106.97€ | 0.65% |